We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:GILD
​
​
logo

Gilead Sciences (GILD)

Nasdaq • GILD • US3755581036

Ex-dividend 15 Dec · 0.82 USD (special)
174.49Last close
Market Closed
Ex-dividend 15 Dec · 0.82 USD (special)
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Nov 3, 2026, ORTEX estimates 1.6% of free float is sold short, 3.1 days to cover, cost to borrow 0.4%.

Market Cap

216b USD | # 80 in US

Volume

6.14m shares | 917.44m USD

Shares Outstanding

1.24b

Free Float Shares

99.79% | 1.24b

DB:GIS|
DB:GIS0|
XTRA:GIS|
LSE:0QYQ|
TSX:GILD|
SWX:GILD|
BOVESPA:GILD34|
BIT:1GILD|
BASE:GILD|
BASE:GILDD|
BASE:GILDD|
WBAG:GILD

News

GILD key data

Gilead Sciences (Nasdaq: GILD) has a market capitalization of $216.43B. Last close $174.49 (as of 2026-11-05); 52-week range $116.88 to $175.65. ORTEX data as of 2026-11-03: short interest is 1.64% of free float, 3.1 days to cover and the average cost to borrow is 0.4%.

Latest on GILD

  • Oct 31, 2026Gilead Surges 9% as Wall Street Lifts Targets Across the Board
  • Sep 25, 2026GILD Bears Exit as Options Market Turns Bullish
All GILD news on ORTEX News
  • GILD news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.